Odyssean »

Medpace Hldgs shares owned by Odyssean

Quarter-by-quarter ownership of Medpace Hldgs (MEDP) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Medpace Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Medpace Hldgs held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Medpace Hldgs by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.4M 6.4k 529.59

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Medpace Hldgs

BlackRock
AQR Capital Management
Vanguard Portfolio Management
Vanguard Capital Management
Geode Capital Management
State Street Corporation
Daniel D. Thurber
Invesco
Baillie Gifford & Co
Arrowstreet Capital, Limited Partnership
Renaissance Technologies
Dimensional Fund Advisors
UBS Group
T. Rowe Price Associates
Morgan Stanley

View all funds holding Medpace Hldgs